Theravance Biopharma (TBPH) Total Debt Growth (3y) (2021 - 2022)

Theravance Biopharma (TBPH) Total Debt Growth (3y) (2021 - 2022) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt Growth (3y) (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	50.25%
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	25.25%
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	0.07%
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Theravance Biopharma	864.82 Mn	470.15 Mn	-	-

Download Data